Science Explorer Interactive view Map
Topic · Endocrinology, Diabetes and Metabolism

Growth Hormone and Insulin-like Growth Factors

Growth Hormone and Insulin-like Growth Factors is a research topic within Endocrinology, Diabetes and Metabolism. Science Explorer counts 51k research works in it since 1950. 19.1% of them reached the world's top 10% most cited for their field and year.

This cluster of papers explores the role of insulin-like growth factors (IGFs) in various aspects of health and disease, including their involvement in cancer development and progression, regulation of metabolism, impact on bone growth, neuroendocrine control, and association with conditions like hypopituitarism. It also discusses the signaling pathways and potential therapeutic implications related to IGFs.

  • Insulin-like Growth Factors
  • IGF-1
  • Growth Hormone
  • Cancer
  • Metabolism
  • Hypopituitarism
  • Receptor Signaling
  • Bone Growth
  • Neuroendocrine Control
  • Prolactin
Research works
51k
fractional, since 1950
In the world top 10%
9.8k
per year above
Top-10% rate
19.1%
share of its works in the world top 10%
Growth, 2013–17 → 2018–22
-9%
the tick is no change

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Growth Hormone and Insulin-like Growth Factors research?

By volume, the United States and China publish the most (686 and 626 works in 2022–2025).

By volume, 2022–2025

  1. 1 United States 686 works
  2. 2 China 626 works
  3. 3 Italy 208 works
  4. 4 India 188 works
  5. 5 Japan 141 works
  6. 6 Türkiye 136 works
  7. 7 United Kingdom 124 works
  8. 8 Germany 122 works
  9. 9 Brazil 112 works
  10. 10 France 98 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 28.1%China: 25.7%Italy: 8.5%India: 7.7%6 others listed: 30.0%28%largest
United States686 · 28.1%China626 · 25.7%Italy208 · 8.5%India188 · 7.7%6 others listed733 · 30.0%

Shares of the rows listed above, not of the whole node.

Which institutions lead Growth Hormone and Insulin-like Growth Factors research?

By volume in 2022–2025, Chinese Academy of Medical Sciences & Peking Union Medical College publishes the most Growth Hormone and Insulin-like Growth Factors research, followed by Harvard University and University of Naples Federico II.

By volume, 2022–2025

  1. 1 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 16 works
  2. 2 Harvard UniversityUnited States 12 works
  3. 3 University of Naples Federico IIItaly 12 works
  4. 4 Peking Union Medical College HospitalChina 12 works
  5. 5 University of BaghdadIraq 11 works
  6. 6 University of North Carolina at Chapel HillUnited States 11 works
  7. 7 Tel Aviv UniversityIsrael 11 works
  8. 8 Istituti di Ricovero e Cura a Carattere ScientificoItaly 11 works
  9. 9 Universidade de São PauloBrazil 11 works
  10. 10 University of PaduaItaly 11 works

Where is Growth Hormone and Insulin-like Growth Factors research done?

The largest centres of Growth Hormone and Insulin-like Growth Factors research in 2022–2025 are Beijing (China), Shanghai (China), Tokyo (Japan) and São Paulo (Brazil). Among places with at least 20 works in it, it is an unusually large share of all research in Bethesda.

Largest cities, 2022–2025

  1. 1 Beijing China 100 works
  2. 2 Shanghai China 47 works
  3. 3 Tokyo Japan 43 works
  4. 4 São Paulo Brazil 43 works
  5. 5 Guangzhou China 41 works
  6. 6 Paris France 41 works
  7. 7 Rome Italy 39 works
  8. 8 London United Kingdom 39 works
  9. 9 New York United States 37 works
  10. 10 Seoul South Korea 36 works

Where it is the local speciality

  1. BethesdaUS · 21.5 works4.8×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Growth Hormone and Insulin-like Growth Factors than the world average.

See Growth Hormone and Insulin-like Growth Factors on the map

Where is the best place to study Growth Hormone and Insulin-like Growth Factors?

Among universities, judged by research, University of Naples Federico II, Ohio University and Harvard University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 18.45%fractional works in this node (log) →share in the world top 10% →University of Naples Federico II: 12, 28.3%Ohio University: 9, 19.1%Harvard University: 12, 23.6%Tel Aviv University: 11, 18.3%Poznan University of Medical Sciences: 9, 18.1%Chinese Academy of Medical Sciences & Peking Union Medical College: 16, 10.1%Universidade de São Paulo: 11, 31.0%University of Padua: 11, 13.6%Medical University of Silesia: 11, 3.1%University of Turin: 8, 19.3%University of Naples…Harvard UniversityOhio UniversityTel Aviv University
above the meannear itbelow it

One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.

#UniversityScoreTop 10%SpecialisationWorksGrowth
1 University of Naples Federico IIItaly 59.128.3%5.5×12 -8.9%
2 Ohio UniversityUnited States 54.719.1%22.3×9 +4.8%
3 Harvard UniversityUnited States 49.223.6%2.6×12 -12.2%
4 Tel Aviv UniversityIsrael 48.718.3%5.6×11 +3.7%
5 Poznan University of Medical SciencesPoland 48.418.1%14.7×9 -16.1%
6 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 47.810.1%4.4×16 +64.6%
7 Universidade de São PauloBrazil 46.531.0%1.7×11 -9.6%
8 University of PaduaItaly 41.713.6%3.7×11 +67.7%
9 Medical University of SilesiaPoland 41.63.1%15.9×11 +30.9%
10 University of TurinItaly 34.119.3%4.7×8 -61.0%

Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.

Is Growth Hormone and Insulin-like Growth Factors research growing?

Output in 2018–2022 was 9% lower than in 2013–2017, peaking in 2008.

19801990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.